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ABSTRACT 
Sir William Osler meticulously described the clinical manifestations of infective endocarditis 
in 1885, concluding that: “few diseases present greater difficulties in the way of diagnosis…. 
which in many cases are practically insurmountable.” Even with modern investigation 
techniques, diagnosing infective endocarditis can be hugely challenging, yet is critically 
important in patients presenting with stroke (both cerebral infarction and intracranial 
haemorrhage), its commonest neurological complication. In ischaemic stroke, intravenous 
thrombolysis carries an unacceptably high risk of intracranial haemorrhage, while in 
intracerebral haemorrhage, mycotic aneurysms require urgent treatment to avoid re-bleeding; 
and in all cases, prompt treatment with antibiotics and valve surgery may be life-saving. Here 
we describe typical presentations of ischaemic stroke and intracerebral haemorrhage caused by 
infective endocarditis. We review the diagnostic challenges, the importance of rapid diagnosis, 
treatment options, and controversies. 
 
CLINICAL CASE REPORTS  
Case Report 1 
A 60-year old man presented to the hyperacute stroke unit with acute speech problems and 
right-sided hemiparesis. He had a background of diabetes and hypertension. Four months 
previously he had been admitted with a left middle cerebral artery ischaemic stroke due to a 
cortical branch occlusion, but no cause had been identified: the extracranial and intracranial 
arteries were normal and there was no abnormality on a transthoracic echocardiogram or 
cardiac rhythm monitoring.  After full investigation, the stroke was considered to be due to 
proximal embolism of undetermined source, probably cardiac.  His CRP was elevated on 
admission 95mg/L but dropped within the first few days to 33mg/L whereupon it seemed to 
stabilise but never dropped lower than this.  After discharge, he reported muscle pain, weight 
loss and fatigue, for which investigations showed persistently raised inflammatory markers 
(CRP 61mg/L, ESR 79mm/hr), negative autoimmune screen and low complement C4. A repeat 
transthoracic echocardiogram and CT-PET of the whole body were normal. He was treated 
with prednisolone for a presumed diagnosis of polymyalgia rheumatica, with two doses of 
intravenous steroid given for ongoing muscle pains the week before admission with another 
stroke. On this second admission, he presented with sudden word-finding difficulties and mild 
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right arm weakness.  CT imaging showed an acute left posterior cerebral artery territory infarct 
in the temporo-occipital region and an established left postero-lateral temporal lobe infarct in 
the middle cerebral artery territory (Figure 1, panel A). He was not within the time window for 
intravenous thrombolysis. The following day he had a fever with a temperature of 38.4°C; 
examination revealed right basal chest crackles, a loud systolic murmur and finger splinter 
haemorrhages.   Blood tests showed CRP 64mg/L, ESR 40mm/hr, and white cell count 
8x109/L. Blood cultures grew Abiotrophia defectiva, a nutritionally variant streptococcus 
constituent of normal oral flora. He was commenced on four hourly high dose intravenous 
amoxicillin. An urgent transthoracic echocardiogram showed vegetations on the aortic and 
mitral valves, with moderate to severe aortic and mitral regurgitation but good left ventricular 
function. Urgent mechanical mitral and aortic valve replacement was performed. He was 
subsequently anticoagulated with warfarin, and transferred for further neurorehabilitation. 
Case Report 2 
A 37-year old man presented to the hyperacute stroke unit with sudden onset left-sided 
weakness and sensory disturbance. He had no significant past medical history, except that over 
the past three months he had been feeling non-specifically unwell with intermittent fevers and 
night sweats. He had attributed these symptoms to a viral infection, which was prevalent in 
staff and pupils in the school in which he worked as a teacher. GP records indicated that a 
blood test two months previously had shown an elevated CRP of 96mg/L and deranged liver 
function tests, but examination had revealed no explanation for these findings.   When admitted 
to the stroke unit he had left hemiparesis and sensory loss; a systolic murmur was audible on 
examination.   Admission blood tests showed raised CRP at 66mg/L, with a normal white cell 
count.   CT head showed an intracerebral haemorrhage in the right frontal lobe (Figure 1, panel 
B).   Subsequent cerebral digital subtraction angiography revealed a 4mm mycotic aneurysm 
(Figure 1, panel C), which was successfully treated by endovascular glue embolisation. An 
urgent transthoracic echocardiogram showed an 11mm vegetation on the posterior leaflet of 
the mitral valve (Figure 1, panel D).  Blood cultures grew Streptococcus sanguinis, a member 
of the viridans streptococci group, which is present in dental plaque. He was treated with 
intravenous antibiotics for 6 weeks, and subsequently had a mitral valve repair. 
 
DISCUSSION 
 4 
Cerebral complications occur in up to 55% of patients with infective endocarditis, often before 
the diagnosis of infective endocarditis is made, and include stroke, brain abscess and meningo-
encephalitis.1-3. In-hospital case fatality of infective endocarditis is about 20%,1 and is even 
higher with neurological involvement. Stroke is the commonest neurological complication, and 
occurs in about 35% of cases of infective endocarditis; a further 30% have “silent” 
cerebrovascular lesions (iscahemic or hemorrhagic) detectable on MRI.2 Both symptomatic 
ischaemic stroke and intracerebral haemorrhage occur, the latter sometimes associated with a 
demonstrable mycotic aneurysm. Mortality from stroke due to infective endocarditis seems to 
be higher in patients with prosthetic heart valves, intracerebral hemorrhage, Staphylococcus 
aureus infection, advanced age, cardiac complications, emergency heart surgery, and septic 
shock. 
 
Diagnosis of endocarditis in patients with stroke 
Infective endocarditis has a highly variable clinical presentation, which may be acute and 
rapidly progressive, or may have a longer and non-specific prodrome. An acute presentation of 
infective endocarditis with fevers and congestive heart failure is more easily recognized than a 
more insidious sub-acute presentation.  
The non-specific preceding systemic symptoms in both of our cases – initially attributed to 
alternative diagnoses – are key to alerting clinicians to the possibility of subacute infective 
endocarditis as a cause of an acute stroke. It is particularly important that clinicians specifically 
ask about preceding systemic prodromal symptoms when faced with any unexplained stroke 
(for example a younger patient with no known vascular risk factors, as in our second case). 
These symptoms are often non-specific; fevers and rigors/chills are most common, but weight 
loss, poor appetite, night sweats, headache, general malaise, cough, myalgia and joint pains 
can all occur. Infective endocarditis should be suspected in any patient with unexplained stroke 
who has fever (especially with bacteraemia), cardiac risk factors (previous infective 
endocarditis, valvular heart disease including congenital heart disease, or a prosthetic valve), 
or non-cardiac risk factors (intravenous drug use, immunosuppression, or a recent dental or 
surgical procedure). The combination of unexplained symptomatic or asymptomatic ischaemic 
and haemorrhagic cerebral lesions together (especially if multiple) should also raise suspicion 
of endocarditis. Cerebral microbleeds on blood-sensitive MRI are seen in about 60% of patients 
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with infective endocarditis, and if numerous (especially in a younger patient) can be a useful 
clue (Figure 2)4.  
The diagnosis of infective endocarditis is typically based on a combination of features from 
amongst the history, examination and investigation results, rather than on a single definitive 
test. Cardiac auscultation on examination, observation for peripheral stigmata of infective 
endocarditis, temperature measurement and checking inflammatory markers are also essential 
in the acute assessment of all patients with acute stroke. Blood cultures and echocardiography 
are particularly important. Table 1 provides a list of the frequency of clinical and laboratory 
findings relevant to diagnosing infective endocarditis from a large multicenter study including 
patients diagnosed with definite infective endocarditis5.  
The diagnosis may be straightforward if classical and specific signs of endocarditis are present: 
Janeway lesions (non-tender erythematous macules on the palms and soles); Osler nodes 
(tender, subcutaneous violaceous nodules on the fingers, toes, thenar or hypothenar eminences) 
and Roth spots (haemorrhagic, oedematous lesions of the retina with pale centres). Janeway 
lesions are presumed embolic phenomena, whereas Osler nodes and Roth spots are thought to 
be immunological in origin. These classical findings are highly specific, but not very common 
(Table 1). Splinter haemorrhages are not so specific, especially if only one or two are found. 
Furthermore, the peripheral signs due to systemic embolism can be absent in solely right heart 
infection, which includes intravenous drug users or those with very acute infection. Although 
fever is nearly always present in infective endocarditis (in one large study over 95% of patients 
had a fever >38 degrees5), in acute stroke, fever is often secondary to a complication, for 
example due to pneumonia, urinary tract infection (UTI), or sepsis, so fever in isolation is not 
a useful pointer to the possibility of infective endocarditis. Nearly all patients with left heart 
infective endocarditis have a heart murmur on auscultation, so absence of this sign should lead 
to questioning the diagnosis; however, murmurs are not so common in right heart infective 
endocarditis.  
Blood inflammatory markers in infective endocarditis are highly sensitive but not very specific, 
partly because infections often complicate acute stroke; they include elevated erythrocyte 
sedimentation rate or C-reactive protein. Since infectious endocarditis is one of the few 
conditions causing a highly elevated ESR, a level of >100mm/hr in a patient with acute stroke 
without an alternative explanation should raise diagnostic suspicion. Positive rheumatoid factor 
is an immunological phenomenon present in about 5% of cases. Hyperglobulinaemia, 
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cryoglobulinaemia, circulating immune complexes, low complement, and false-positive 
serologic tests for syphilis can also occur. Microscopic haematuria and proteinuria may be 
present; red blood cell casts in the urine, suggesting glomerulonephritis, may be particularly 
helpful, and this finding is a minor diagnostic criterion for infective endocarditis. At least three 
sets of blood cultures should be taken from separate venepuncture sites before starting 
antibiotics, which will capture 96% to 98% of cases of bacteraemia.6 Antibiotics should not be 
delayed if the diagnosis is suspected and the patient is clinically unstable. Electrocardiography 
may demonstrate new or evolving conduction disease (first-degree atrioventricular block, 
bundle branch block, or complete heart block), reflecting paravalvular or myocardial extension 
of infection. MRI of the brain can be helpful in the diagnosis of stroke due to endocarditis: as 
well as showing the symptomatic ischaemic or haemorrhagic lesion, asymptomatic 
abnormalities are very frequently detected. In one study of 130 patients, 106 (82% [95% CI, 
75% to 89%]) patients had clinically silent lesions; these were ischemic lesions in 68, 
microbleeds in 74, and silent aneurysms in 10. 7 
The Duke diagnostic criteria have been validated in pathologically proven infective 
endocarditis, with sensitivity >80%8 and almost 100% specificity in patients with acute 
unexplained fever9. The modified Duke criteria give major and minor criteria required for the 
diagnosis of infective endocarditis (Table 2)10: Definite infective endocarditis is diagnosed by: 
two major clinical criteria; one major and three minor clinical criteria; or five minor clinical 
criteria. However, these criteria should always be combined with clinical judgement of the pre-
test probability. The diagnostic accuracy may be lower in suspected prosthetic valve infective 
endocarditis, right-sided infective endocarditis, cardiac device infection, and has not been 
evaluated specifically in patients with acute stroke11. Thus, the diagnosis of infective 
endocarditis in a patient with stroke should not be based entirely on fulfillment of these criteria.  
A positive blood culture for an organism compatible with infective endocarditis in a stroke 
patient should always lead the clinician to review the history and seek out the possible diagnosis 
of infective endocarditis.   There is a high yield from a first blood culture: 96% in streptococcal 
infective endocarditis and 82% of cases caused by other organisms in one series of 206 cases.12 
In those who are culture negative, fastidious organisms (for example Coxiella,and Bartonella) 
should be considered, and the appropriate serologies sent for confirmation12.  The HACEK 
group (Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium 
hominis, Eikenella corrodens and Kingella kingae) are fastidious Gram negative organisms 
which will be cultured by the laboratory if the appropriate clinical details are provided. 
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Echocardiography (transthoracic and, if necessary, transoesophageal) should be urgently 
undertaken in all patients with stroke if infective endocarditis is suspected, as prompt diagnosis 
allows life-saving treatment, including antibiotics and valve replacement.  Transoesophageal 
echocardiography is more sensitive for diagnosis: in one series, trans-thoracic 
echocardiography (TTE) only identified vegetations in 32% of cases, while trans-oesophageal 
echocardiography did so in 19% of those with a negative TTE and in 21% of those with an 
indeterminate TTE result.13 Other echocardiographic findings include abscess and moderate or 
severe new valvular regurgitation.  Vegetation length of longer than 10mm has been reported 
to be predictive of embolic events, while >15mm predicted higher mortality.14 
 
Treatment of stroke associated with infective endocarditis 
General treatment 
Optimum management of infective endocarditis always requires input from multiple clinical 
teams; in stroke patients this might need to include neurologists or stroke physicians, 
cardiologists and cardiothoracic surgeons, neuroradiologists, neurosurgeons, anaesthetists, and 
microbiology and infectious disease specialists. Antibiotics are the mainstay of treatment and 
appear to reduce the risk of stroke from 0.5% per day to 0.3% per day15. Suggested antibiotic 
regimens for native and prosthetic valve endocarditis usually include combination intravenous 
therapy (e.g. amoxicillin and gentamicin for native valve infective endocarditis) but local 
microbiological expertise is essential. Cardiac valve surgery is needed in about 40–50% of 
patients with infective endocarditis16 for three main indications: heart failure due to valve 
dysfunction, uncontrolled infection, and prevention of embolism. The aims of surgery are to 
eradicate infection and normalize heart anatomy. Surgery may involve valve repair or 
bioprosthetic or mechanical replacement; specific evidence for the best approach or optimum 
timing is not available. In practice, because of concerns about the risks of surgery, anaesthesia 
and cardiopulmonary bypass, valve surgery is traditionally delayed until patients with infective 
endocarditis-related stroke are neurologically stable, typically for about two weeks. However, 
recent data suggests that early surgery might be safe in infective endocarditis17 18. A 
randomized study of early vs. standard timing of surgery found that death from any cause, 
embolic events, or recurrence of infective endocarditis at 6 months was 3% in the early-surgery 
group and 28% in the conventional treatment group (hazard ratio, 0.08; 95% CI, 0.01 to 0.65; 
P=0.02).17 Current guidelines therefore suggest that after ischaemic stroke, surgery indicated 
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for heart failure, uncontrolled infection, abscess, or persistent high embolic risk should be 
considered early (ie <14 days), in the absence of severely reduced conscious level or 
haemorrhage on cranial CT or MRI.11 In patients with intracranial haemorrhage, neurological 
prognosis is worse, so it is suggested that surgery should generally be postponed for at least a 
month. Cardiac surgery typically requires anticoagulation, so particular caution is needed to 
ensure that intracranial haemorrhage risk is reduced to an acceptable level (e.g. by securing 
ruptured mycotic aneurysms). In practice, timing is decided by multidisciplinary discussion 
between the stroke, anaesthetics, cardiology and cardiac surgery teams, and is generally 
delayed until the patient is neurologically stable. 
 
Ischaemic stroke 
Ischaemic stroke is three times more likely than intracranial haemorrhage in infective 
endocarditis19 and is attributed to the embolization of infected valve material to the brain.  The 
risk of neurologic complications has been suggested to be higher in patients with 
Staphylococcus aureus infective endocarditis, and with multiple valve involvement. The risk 
of stroke might be higher with mitral than aortic valve involvement. 12,20  
Intravenous thrombolysis is the standard acute treatment for ischaemic stroke patients 
presenting within 4.5 hours, but probably carries more hazard than benefit in ischaemic stroke 
due to infective endocarditis. Intracerebral bleeding in infective endocarditis could occur from 
either haemorrhagic transformation of an infarct, rupture of an aneurysm, or from a friable 
inflamed blood vessels due to associated arteritis. The risk of post-thrombolysis intracranial 
haemorrhage has been reported to be higher in infective endocarditis related ischaemic stroke 
than in other patients (in one sample of 222 patients the rate of post-thrombolysis intracerebral 
haemorrhage in infective endocarditis-related ischaemic stroke was 20%, compared to 6.5% in 
patients with ischaemic stroke unrelated to infective endocarditis).21  Moreover, there was a 
significantly lower rate of favourable outcome in the infective endocarditis group (10% versus 
37%; P=0.01).  Thus, it is likely that this large absolute increase in intracerebral haemorhage 
risk outweighs the absolute benefit of treatment in most cases of ischaemic stroke associated 
with infectious endocarditis. However, only a randomized trial could definitively prove that 
there is no net benefit from alteplase in stroke due infective endocarditis. Given the rarity of 
endocarditis related ischaemic stroke, such a trial is not feasible, so clinicians must make an 
informed judgement based on the observational evidence. In our practice, we try to avoid 
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systemic thrombolysis in ischaemic stroke due to infective endocarditis. An alternative 
treatment for some patients might be endovascular clot retrieval treatment (thrombectomy), 
which has recently been shown to be dramatically effective in anterior circulation large vessel 
occlusion; 22 this option is a theoretically attractive option in ischaemic stroke due to infective 
endocarditis, but has not been evaluated in clinical trials or observational studies in this specific 
setting. Furthermore, thrombectomy might have higher risks in infective endocarditis than in 
the trial populations studied, and cannot currently be routinely offered in all stroke centres.  
A key clinical challenge is in recognizing the possibility of infectious endocarditis in the very 
short time window available for effective intravenous thrombolysis in acute ischaemic stroke: 
“red flags” to alert clinicians to the possibility include: young age with no risk factors; multiple 
ischaemic or haemorrhagic brain lesions; known cardiac valve abnormality; intravenous drug 
use; immunosuppression; preceding malaise, myalgia or weight loss; cardiac murmur with 
fever; clinical stigmata of embolism or immune complex formation; or extremely raised 
inflammatory markers (e.g. ESR>100mm / hour).  
Anticoagulation and antiplatelet treatments are also potentially hazardous in infective 
endocarditis, with a substantial risk of intracerebral haemorrhage.  Cerebral microbleeds 
(CMBs) are common in infective endocarditis (Figure 2), and were described in 57% of 
patients in one case series of 60 patients; usually lobar, with an average of about 8 microbleeds 
per patient4; they are probably secondary to inflammation and leakage of the 
microvasculature4, which might contribute to the high risk of intracerebral haemorrhage in 
infective endocarditis, even in the absence of anticoagulation. Intracerebral haemorrhage is 
especially common with Staphylococcus aureus infection, which can be considered when 
making antithrombotic decisions.  Unfortunately, data to guide the use of anticoagulants and 
antiplatelet therapies in infective endocarditis are extremely limited. This decision thus 
presents a dilemma for the clinician who needs to balance the risk of thombo-embolization 
(which might be reduced by anticoagulation) with the risk of intracranial haemorrhage (which 
might be aggravated). In general, there is no evidence to support the use of anticoagulants or 
antiplatelet drugs in acute stroke due to infective endocarditis so these should be avoided in the 
acute phase in the absence of any compelling indication; intra-cardiac thrombus, atrial 
fibrillation or venous thromboembolism might be indications for early anticoagulation. The 
specific question of whether to continue anticoagulants in patients with prosthetic valve 
endocarditis remains unsettled, and no general recommendation can be made; the decision 
needs to individualized, taking account of all available clinical, laboratory and imaging 
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information.  Following infective endocarditis-associated ischaemic stroke with a strong 
indication for anticoagulation it is generally reasonable to delay this by 2 weeks, as is 
conventional for other patients with cardioembolic stroke. An urgent priority in infective 
endocarditis patients at risk of intracerebral haemorrhage is cardiological assessment of valve 
function, and cerebral angiography to look for mycotic aneurysms as these may be amenable 
to intervention, rather than early anticoagulation; this should allow anticoagulation and other 
acute decisions to be based on an informed estimate of the competing risks. In particular this 
information is vital to allow planning of valve surgery, if required.  
Intracerebral haemorrhage 
Intracerebral haemorrhage occurs in approximately 5% of patients with infective endocarditis 
and is thought to be due to haemorrhagic transformation of infarcted brain, septic arteritis and 
vessel wall rupture, or rupture of a mycotic aneurysm23. Mycotic aneurysms in infective 
endocarditis are most frequently found in distal branches of the middle cerebral artery territory. 
Patients with Staphylococcus aureus bacteraemia are more likely to develop intracerebral 
haemorrhage in the first 48 hours after hospital admission. The mortality from ruptured mycotic 
aneurysms has been reported to be as high as 80%. The rebleeding risk of ruptured mycotic 
aneurysms is likely to be high, and all should therefore be considered for endovascular or 
surgical treatment. Clipping may be technically difficult due to an often poorly defined 
aneurysmal neck and vascular fragility Endovascular therapy (coiling or acrylic glue) may be 
more appropriate, especially in patients who are unfit for surgery due to cardiac disease. Indeed, 
surgical treatment of a mycotic aneurysm is a viable option in very few patients – one series of 
179 patients with infective endocarditis-related intracerebral haemorrhage found only 2.2% of 
patients who could be surgically treated.23 The risk of bleeding from unruptured mycotic 
aneurysms is unknown, and patients are not routinely offered treatment for this reason. 
In conclusion, infective endocarditis is a diagnostic and management challenge in the context 
of acute ischaemic stroke and intracerebral haemorrhage. The diagnosis of infective 
endocarditis has important implications for management, which remains challenging due to a 
lack of prospective controlled studies. We emphasize the importance of a multidisciplinary 
collaborative approach to give the best outcomes in this devastating disease.  
 
Key Learning points 
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 Diagnosing infective endocarditis in patients with stroke is challenging but important: in 
ischaemic stroke due to infective endocarditis, systemic thrombolysis carries a high 
bleeding risk and is probably best avoided; endovascular treatment is an alternative for 
large vessel anterior occlusions, though not tested in this specific setting 
 Non-specific prodromal systemic symptoms are key to alerting clinicians to the possibility 
of infective endocarditis in a patient with stroke 
 Antithrombotic drugs should generally be avoided in acute stroke due to infective 
endocarditis because of the high risk of intracerebral haemorrhage  
 Ruptured mycotic aneurysms have a poor prognosis if left untreated, and require urgent 
surgical or endovascular treatment 
 In any stroke patient with infective endocarditis antibiotics and valve surgery may be life-
saving; current evidence favours early surgery (<14 days) in those with ischaemic stroke 
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Figure 1 
(A) Axial CT head of case 1, 6 days after the second admission showing a left occipital 
infarct (arrowed). (B) Initial axial CT head of case 2 showing right hemisphere frontal 
intraparenchymal haemorrhage (arrowed) with contrast pooling outlining the aneurysmal sac. 
(C) Intra-arterial digital subtraction cerebral angiogram of case 2 showing mycotic aneurysm 
(arrowed). (D) Echocardiogram of case 2 showing a vegetation (arrowed) on the posterior 
mitral valve leaflet. 
 
Figure 2 
(A) and (B) Axial T2*-weighted gradient-echo MRI showing cerebral microbleeds both 
supratentorially and infratentorially (white arrows) and a larger hypointense lesion (white 
arrowhead, left panel), which on intra-arterial digital subtraction angiography was found to be 
a mycotic aneurysm, subsequently treated with glue embolization.  
  
 13 
Table 1. Clinical and laboratory findings and their prevalence in 2781 patients fulfilling 
the Duke criteria for infective endocarditis (modified from reference 4) 
Finding  (%) of Patients 
Fever of more than 38°C  96 
Splinter hemorrhages  8 
Osler nodes  3 
Janeway lesions  5 
Roth spots  2 
Vascular embolic event  17 
Conjunctival hemorrhage  5 
Splenomegaly  11 
New murmur  48 
Worsening of old murmur  20 
Elevated ESR  61 
Elevated C-reactive protein level  62 
Elevated rheumatoid factor  5 
Hematuria  26 
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Table 2: Modified Duke criteria for diagnosis of infective endocarditis  (from Li et al): 
The diagnosis of infective endocarditis is definite with: one pathological criterion; two 
major criteria; one major and three minor criteria; or five minor criteria  
Pathological criteria  
Microorganisms on histology or culture of a vegetation or intracardiac abscess  
Vegetation or intracardiac abscess showing active endocarditis on histology  
Major clinical criteria  
1) Blood cultures positive for infective endocarditis  
Typical microorganisms consistent with IE from two separate blood cultures: 
• Staphylococcus aureus, viridans streptococci, Streptococcus bovis, HACEK (Haemophilus, 
Aggregatibacter, Cardiobacterium, Eikenella corrodens, Kingella) group, or community-
acquired enterococci, in the absence of a primary focus  
or  
Microorganisms consistent with infective endocarditis from persistently positive blood 
cultures:  
 At least two positive blood cultures from blood samples drawn >12 h apart, or  
 All of three, or most of ≥4 separate cultures (with first and last sample >1 h apart) or  
 Single positive culture for Coxiella burnetii, or phase 1 IgG antibody titre >1:800  
2) Evidence of endocardial involvement  
Echocardiography positive for infective endocarditis  
• Defined by presence of a vegetation, abscess, or new partial dehiscence of prosthetic valve  
New valvular regurgitation (note: increase or change in pre-existing murmur is not  
sufficient) 
Minor clinical criteria  
1) Predisposition: predisposing heart condition, intravenous drug use  
2) Fever: temperature >38°C  
3) Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, 
intracranial haemorrhages, conjunctival haemorrhages, Janeway lesions  
4) Immunological phenomena: glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor  
5) Microbiological evidence: positive blood culture that does not meet a major criterion or 
serological evidence of active infection with organism consistent with infective endocarditis  
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